About Xihua Pharmaceutical:
Established in March 2021, Shanghai Xihua Pharmaceutical Co., LTD. has served nearly 600 Chinese and international customers. Their services include API process R&D, analysis and development of large and small molecule drugs, gene and cell therapy products, innovative drug formulation R&D, clinical and commercial preparation production, drug regulatory submission, and CMC integrated CDMO technology. Xihua’s clientele includes the top 50 pharmaceutical companies in China, most of the world’s top 10 pharmaceutical companies, and numerous smaller biotech ventures.
Our Solutions
To enhance project development efficiency, streamline the document collection process, and strengthen compliance controls, Xihua Pharmaceutical partnered with Neotrident in 2023. Together, they leveraged Neotrident’s SaaS cloud platform to quickly implement a digital R&D data management system consisting of Project Management (PM), Electronic Lab Notebooks (ELN), and Chemical Inventory Management System (CIMS). Unlike traditional on-premise deployments, the iLabPower SaaS cloud platform was already hosted on cloud servers, enabling a swift system setup and deployment. This approach significantly reduced both implementation and ongoing operational costs, allowing Xihua to enjoy a cost-effective, time-efficient, and high-yield solution.
Results & Benefits
By using the iLabPower PM system, Xihua Pharmaceutical was able to break down tasks and milestones for each project, facilitating refined project management. This reduced execution risks and allowed for rapid project delivery while ensuring compliance and product quality. Additionally, project information was automatically synced to the ELN and CIMS systems, linking all experimental records and material usage to specific projects. This provided a comprehensive view of project data and material cost management.
The ELN system further streamlined the workflow by providing experimental templates, experimental cloning, and mobile app functionalities. These tools simplified the process of organizing experimental data and freed scientists from the laborious task of manual data management. ELN’s complete audit trail and online record approval workflows strengthened compliance control over R&D records, ensuring adherence to regulatory standards.
The CIMS system’s barcode material management system allowed for precise lifecycle tracking of each material. This included features such as online material inventory queries, mobile app-based QR code scanning for self-service claiming, and rapid import of material data into ELN records. This significantly boosted the efficiency of Xihua’s laboratory material management process.
With the support of the iLabPower platform, Xihua Pharmaceutical achieved the following:
- Standardized project management processes with real-time monitoring of tasks and project progress.
- Reduced project risks through effective budget control and milestone tracking.
- Organized experiment records and related documents by project, simplifying the compilation of application materials.
- Strengthened compliance with standardized experimental records, full audit tracking, and streamlined record approval workflows.
- Achieved lifecycle management for chemicals and materials, with automated generation of material ledgers and statistical reports, minimizing procurement duplication, reducing waste, and lowering laboratory costs.